Literature DB >> 9678752

Apoptosis induced by NK cells is modulated by the NK-active cytokines IL-2 and IL-12.

L Rodella1, R Rezzani, G Zauli, A R Mariani, R Rizzoli, M Vitale.   

Abstract

NK cells kill sensitive targets via exocytosis of cytoplasmic granules containing membrane damaging perforins and DNA damaging granzymes. Therefore, the target cell can either die by necrosis or by apoptosis. A third, non-secretory, mechanism of killing mediated by Fas-FasL interaction can be used by activated NK cells to kill Fas+ targets. Here, we have studied the modulation exerted by two NK active cytokines, IL-2 and IL-12, on the apoptosis-inducing activity of NK cells in NK-sensitive Fas- K562 and NK-insensitive Fas+ Raji cells. Our results show that apoptosis is preferentially induced at low target:effector ratios. Resting NK cells virtually do not induce apoptosis in target cells while IL-2 stimulation endows NK cells with the capacity of inducing apoptosis and IL-12 further enhances this effect against both targets. Finally, we demonstrate that cytokine-stimulated NK cells use both granzyme and Fas-FasL pathways of apoptosis induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678752     DOI: 10.1093/intimm/10.6.719

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  4 in total

1.  Correlation between the expression of Fas, Bcl-2 in peripheral blood lymphocytes and the level of IFN-gamma, IL-4 in serum of patients with condyloma acuminata.

Authors:  Houjun Liu; Nengxing Lin; Yating Tu; Zhixiang Liu; Changzheng Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

2.  The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNA.

Authors:  Ute Kaim; Andreas Moritz; Klaus Failing; Wolfgang Baumgärtner
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

3.  Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study.

Authors:  Monika Holubova; Michaela Miklikova; Martin Leba; Daniel Georgiev; Pavel Jindra; Martin Caprnda; Rachele Ciccocioppo; Peter Kruzliak; Daniel Lysak
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

4.  Anti-Cancer Effects of Synergistic Drug-Bacterium Combinations on Induced Breast Cancer in BALB/c Mice.

Authors:  Menaga Subramaniam; Norhafiza M Arshad; Kein Seong Mun; Sharan Malagobadan; Khalijah Awang; Noor Hasima Nagoor
Journal:  Biomolecules       Date:  2019-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.